Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
19.69
+0.51 (2.66%)
At close: Feb 4, 2026, 4:00 PM EST
19.69
0.00 (0.00%)
After-hours: Feb 4, 2026, 4:10 PM EST
2.66% (1D)
| Assets | $12.54M |
| Expense Ratio | 0.55% |
| PE Ratio | 19.22 |
| Shares Out | 600,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.32% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 6.10% |
| Volume | 683 |
| Open | 19.49 |
| Previous Close | 19.18 |
| Day's Range | 19.49 - 19.74 |
| 52-Week Low | 15.37 |
| 52-Week High | 22.34 |
| Beta | n/a |
| Holdings | 52 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
24.55% of assets| Name | Symbol | Weight |
|---|---|---|
| Enphase Energy, Inc. | ENPH | 2.84% |
| F5, Inc. | FFIV | 2.55% |
| Merck & Co., Inc. | MRK | 2.53% |
| Organon & Co. | OGN | 2.46% |
| Bristol-Myers Squibb Company | BMY | 2.46% |
| BioMarin Pharmaceutical Inc. | BMRN | 2.37% |
| Illumina, Inc. | ILMN | 2.37% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.34% |
| Gentex Corporation | GNTX | 2.33% |
| Zoom Communications, Inc. | ZM | 2.32% |
Performance
INVN had a total return of -7.51% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.56%.
